Cargando…
Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997263/ https://www.ncbi.nlm.nih.gov/pubmed/31734822 http://dx.doi.org/10.1007/s10549-019-05498-0 |
| _version_ | 1783493660340387840 |
|---|---|
| author | Wardell, Suzanne E. Yllanes, Alexander P. Chao, Christina A. Bae, Yeeun Andreano, Kaitlyn J. Desautels, Taylor K. Heetderks, Kendall A. Blitzer, Jeremy T. Norris, John D. McDonnell, Donald P. |
| author_facet | Wardell, Suzanne E. Yllanes, Alexander P. Chao, Christina A. Bae, Yeeun Andreano, Kaitlyn J. Desautels, Taylor K. Heetderks, Kendall A. Blitzer, Jeremy T. Norris, John D. McDonnell, Donald P. |
| author_sort | Wardell, Suzanne E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6997263 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69972632020-02-19 Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy Wardell, Suzanne E. Yllanes, Alexander P. Chao, Christina A. Bae, Yeeun Andreano, Kaitlyn J. Desautels, Taylor K. Heetderks, Kendall A. Blitzer, Jeremy T. Norris, John D. McDonnell, Donald P. Breast Cancer Res Treat Correction Springer US 2019-11-16 2020 /pmc/articles/PMC6997263/ /pubmed/31734822 http://dx.doi.org/10.1007/s10549-019-05498-0 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Correction Wardell, Suzanne E. Yllanes, Alexander P. Chao, Christina A. Bae, Yeeun Andreano, Kaitlyn J. Desautels, Taylor K. Heetderks, Kendall A. Blitzer, Jeremy T. Norris, John D. McDonnell, Donald P. Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy |
| title | Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy |
| title_full | Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy |
| title_fullStr | Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy |
| title_full_unstemmed | Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy |
| title_short | Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy |
| title_sort | correction to: pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997263/ https://www.ncbi.nlm.nih.gov/pubmed/31734822 http://dx.doi.org/10.1007/s10549-019-05498-0 |
| work_keys_str_mv | AT wardellsuzannee correctiontopharmacokineticandpharmacodynamicanalysisoffulvestrantinpreclinicalmodelsofbreastcancertoassesstheimportanceofitsestrogenreceptoradegraderactivityinantitumorefficacy AT yllanesalexanderp correctiontopharmacokineticandpharmacodynamicanalysisoffulvestrantinpreclinicalmodelsofbreastcancertoassesstheimportanceofitsestrogenreceptoradegraderactivityinantitumorefficacy AT chaochristinaa correctiontopharmacokineticandpharmacodynamicanalysisoffulvestrantinpreclinicalmodelsofbreastcancertoassesstheimportanceofitsestrogenreceptoradegraderactivityinantitumorefficacy AT baeyeeun correctiontopharmacokineticandpharmacodynamicanalysisoffulvestrantinpreclinicalmodelsofbreastcancertoassesstheimportanceofitsestrogenreceptoradegraderactivityinantitumorefficacy AT andreanokaitlynj correctiontopharmacokineticandpharmacodynamicanalysisoffulvestrantinpreclinicalmodelsofbreastcancertoassesstheimportanceofitsestrogenreceptoradegraderactivityinantitumorefficacy AT desautelstaylork correctiontopharmacokineticandpharmacodynamicanalysisoffulvestrantinpreclinicalmodelsofbreastcancertoassesstheimportanceofitsestrogenreceptoradegraderactivityinantitumorefficacy AT heetderkskendalla correctiontopharmacokineticandpharmacodynamicanalysisoffulvestrantinpreclinicalmodelsofbreastcancertoassesstheimportanceofitsestrogenreceptoradegraderactivityinantitumorefficacy AT blitzerjeremyt correctiontopharmacokineticandpharmacodynamicanalysisoffulvestrantinpreclinicalmodelsofbreastcancertoassesstheimportanceofitsestrogenreceptoradegraderactivityinantitumorefficacy AT norrisjohnd correctiontopharmacokineticandpharmacodynamicanalysisoffulvestrantinpreclinicalmodelsofbreastcancertoassesstheimportanceofitsestrogenreceptoradegraderactivityinantitumorefficacy AT mcdonnelldonaldp correctiontopharmacokineticandpharmacodynamicanalysisoffulvestrantinpreclinicalmodelsofbreastcancertoassesstheimportanceofitsestrogenreceptoradegraderactivityinantitumorefficacy |